MARLON VAZQUEZ: Open Payments
NPI 1669671590 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,835 in 163 payments from 20 companies in 2025. Trend: 2023 $83 · 2024 $1,967 · 2025 $3,835
Food & beverage: $3,835
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 29 | $732 |
| Otsuka America Pharmaceutical, Inc. | 26 | $626 |
| Neurocrine BioSciences, Inc. | 14 | $409 |
| ABBVIE INC. | 13 | $273 |
| Vanda Pharmaceuticals Inc. | 8 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $216 |
| Janssen Pharmaceuticals, Inc | 8 | $197 |
| E.R. Squibb & Sons, L.L.C. | 9 | $187 |
| Braeburn Inc. | 5 | $144 |
| Corium, LLC | 7 | $136 |
Products named: Auvelity, REXULTI, INGREZZA, VRAYLAR, FANAPT, CAPLYTA, ABILIFY ASIMTUFII, COBENFY.
Industry payments across FL — which companies pay providers there.
